Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1X14
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,798
Award facts
- Contract value 100% obligated
- $45,798.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $45,798 delivery order to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 30 mg tablets (30-count units) on January 23, 2026, with an ultimate completion date of January 26, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a wide range of pharmaceutical products across multiple therapeutic domains through competitively awarded agreements. This specific delivery order for RINVOQ, a prescription medication used in rheumatology treatment, exemplifies the company's role in fulfilling essential pharmaceutical requirements for the Department of Defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DR26F1X14?
SPE2DR26F1X14 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F1X14 worth?
The government has obligated $45,798 on SPE2DR26F1X14.
Is contract SPE2DR26F1X14 an order under another contract?
Yes. SPE2DR26F1X14 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1X14 competed?
The extent of competition for SPE2DR26F1X14 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award